Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FX2EL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $167,946
Award facts
- Contract value 100% obligated
- $167,946.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $167,946.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of ALYFTREK 10-50-125 mg tablets in quantities of 14 units. The award carries an ultimate completion date of September 8, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its principal location in Park Ridge. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million single-award vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facility medical supply needs.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing Defense Logistics Agency contracts for an extensive portfolio of pharmaceutical items including prescription drugs, biologics, and medical consumables. The company's federal contracting history demonstrates substantial experience delivering specialized pharmaceutical products to Department of Defense healthcare sites nationwide. As a registered small business in the System for Award Management since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust track record of pharmaceutical product deliveries to military and federal healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FX2EL?
SPE2DB25FX2EL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FX2EL worth?
The government has obligated $167,946 on SPE2DB25FX2EL.
Is contract SPE2DB25FX2EL an order under another contract?
Yes. SPE2DB25FX2EL is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EL competed?
The extent of competition for SPE2DB25FX2EL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award